---
title: "Cangzhou Mingzhu: Net profit of 82.8067 million yuan in the first half of 2025, a year-on-year decrease of 6.15%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254787910.md"
description: "Cangzhou Mingzhu announced that in the first half of 2025, operating income was 1.319 billion yuan, a year-on-year increase of 6.88%. Net profit was 82.8067 million yuan, a year-on-year decrease of 6.15%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital by converting reserves into shares"
datetime: "2025-08-27T10:52:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254787910.md)
  - [en](https://longbridge.com/en/news/254787910.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254787910.md)
generator: "portal-rs"
---

# Cangzhou Mingzhu: Net profit of 82.8067 million yuan in the first half of 2025, a year-on-year decrease of 6.15%

Cangzhou Mingzhu announced that in the first half of 2025, operating income was 1.319 billion yuan, a year-on-year increase of 6.88%. Net profit was 82.8067 million yuan, a year-on-year decrease of 6.15%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves

### Related Stocks

- [002108.CN](https://longbridge.com/en/quote/002108.CN.md)

## Related News & Research

- [Oncoinvent publishes investor presentation on Radspherin alpha therapy for peritoneal metastases](https://longbridge.com/en/news/296323325.md)
- [US Plains HRW Wheat-Basis flat to up with limited trade](https://longbridge.com/en/news/296655424.md)
- [08:31 ETTiger Group Offers Lab Equipment, Plastics Inventory and More from Grow Materials, LLC](https://longbridge.com/en/news/296491453.md)
- [Oncoinvent: RadspherinⓇ delivers promising efficacy and safety for peritoneal metastases with blockbuster potential](https://longbridge.com/en/news/296574345.md)
- [13:35 ETMatan Companies Signs Two New Industrial Leases Totaling More Than 92,000 SF in Frederick, MD](https://longbridge.com/en/news/296641992.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**